China Resources Pharmaceutical Group Limited (HKG:3320)
4.250
-0.050 (-1.16%)
Sep 11, 2026, 4:08 PM HKT
HKG:3320 Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, HKG:3320 stock has a consensus rating of "Buy" and an average price target of $6.51. The average 1-year stock price forecast is 53.18% higher than the current stock price, while the lowest is $5.64 (+32.71%) and the highest is $7.52 (+76.94%).
Price Target: $6.51 (+53.18%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:3320 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 6 | 6 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 10 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $7.00 | Buy | Maintains | $7.00 | +64.71% | Aug 27, 2026 |
Unknown Analyst China Merchants Securities No rating | China Merchants Securities | Buy Maintains $6.30 | Buy | Maintains | $6.30 | +48.24% | Aug 26, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $6.50 | Buy | Maintains | $6.50 | +52.94% | Aug 26, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $7.20 | Buy | Maintains | $7.20 | +69.41% | Aug 26, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Buy Maintains $5.70 | Buy | Maintains | $5.70 | +34.12% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
288.63B
from 269.57B
Increased by 7.07%
Revenue Next Year
299.65B
from 288.63B
Increased by 3.82%
EPS This Year
0.69
from 0.64
Increased by 7.54%
EPS Next Year
0.73
from 0.69
Increased by 6.60%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.